Beat Breast Cancer with Tucaxen 150mg tablethttps://www.magicinepharma.com/tablet/tucaxen-150mg-tabl (Health & Beauty - Health Services)
USAOnlineClassifieds > Health & Beauty > Health Services
Item ID 2510866 in Category: Health & Beauty - Health Services
Beat Breast Cancer with Tucaxen 150mg tablethttps://www.magicinepharma.com/tablet/tucaxen-150mg-tabl | |
Free Online Advertising Free Internet Web Site Advertising. UK Free Classifieds United Kingdom Free Ads Website. 100% Free Ad Posting. Canada Free Ads Popular Online Classifieds in Canada. No Sign up, No Email Required to Post. Tucaxen 150 mg tablet is used in the treatment of breast cancer, and its generic name is Tucatinib. It is target therapy medicine that identifies and stops or kills the cancer cells in the patient's body or shrinks cancer cells. To get this medicine at an affordable price, visit Magicine Pharma to get this medicine with up to 47% discount, or you can call +91 9319113130 or +91 11 4160 3130 to get it at your doorstep. It has several side effects that are not seen in every patient, such as stomach pain, vomiting, fever, headache, diarrhea, cough, muscle pain, rashes, shortness of breath, cough, etc. For fast and better recovery, follow the doctor's prescription. In case of missed or overdose, it is advised to consult a doctor soon for further medical attention. Also, during treatment, try to avoid alcohol consumption and inform all medicines or supplements that you are taking because they might react and cause problems in treatment. | |
| Related Link: Click here to visit item owner's website (1 hit) | |
| Target State: Washington DC Target City : All Cities Last Update : Jan 17, 2024 6:34 AM Number of Views: 76 | Item Owner : Magicine Pharma Contact Email: Contact Phone: 9319113130 |
| Friendly reminder: Click here to read some tips. | |
USAOnlineClassifieds > Health & Beauty > Health Services
© 2025 USAOnlineClassifieds.com
USNetAds.com | GetJob.us | CANetAds.com | UKAdsList.com | AUNetAds.com | INNetAds.com | CNNetAds.com | Hot-Web-Ads.com
2025-01-09 (0.388 sec)